▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3522 by analyst upside · 2026-08-14
AVTR
Avantor, Inc.
Healthcare · Market Cap $9B · P/E 0x
ANALYST PRICE TARGET
+5.2%
implied upside to consensus target
Current Price $13.85
Consensus Target $14.56
Bull Target $19.0
Bear Target $12.0
Analysts Covering 14
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
3
Hold
10
Sell
1
52-Week Low $7.26
52-Week High $15.93
YTD Return +20.9%
FUNDAMENTALS
Market Cap $9B
P/E Ratio (TTM) N/A
Forward P/E 15.7x
EPS (TTM) $-0.85
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $6.6B
Profit Margin -8.8%
52-WEEK RANGE
52-Week Low $7.26
52-Week High $15.93
Current Price $13.85
Bear Target $12.0
Bull Target $19.0
● Now $13.85 ● Target $14.56
TRADING DATA
Avg Volume 10.5M
YTD Return +20.9%
Analyst Count 14
Consensus Hold
Upside to Target +5.2%
Last Updated 2026-08-14

ANALYST SUMMARY

Avantor, Inc. (AVTR) is currently trading at $13.85 with a Wall Street consensus price target of $14.56, implying potential upside of 5.2% over the next 12 months. 14 analysts currently cover AVTR, with a consensus rating of Hold - 21% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $12.0.

AVTR operates in the Healthcare sector with a market capitalisation of $9B. The stock is up 20.9% year-to-date and is currently trading near the upper end of its 52-week range of $7.26 – $15.93.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

UHS +13.3%
Universal Health Services, Inc.
$10B · P/E 7.0x · Hold
QGEN +6.6%
Qiagen N.V.
$9B · P/E 21.9x · Buy
DVA +21.9%
DaVita Inc.
$11B · P/E 15.2x · Hold
FMS +8.8%
Fresenius Medical Care AG
$13B · P/E 12.3x · Hold
HNGE +20.3%
Hinge Health, Inc.
$7B · P/E 10.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for AVTR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Neutral → Neutral 2026-04-30 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-04-30 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-04-15 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-04-06 Building track record
Barclays ↓ Downgrade
Equal-Weight → Underweight 2026-03-06 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-02-13 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-02-12 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-02-12 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
21/30
Consensus clarity
20/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →